Nikola Mitrev

Nikola Mitrev

Auto-generated profile, based on publicly available information

Nikola Mitrev

Department of Gastroenterology Sutherland Hospital Sutherland New South Wales Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2017 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
NMN. Mitrev
N. Mitrev
NCN. Vande Casteele
N. Vande Casteele
CSC. H. Seow
C. H. Seow
JAJ. M. Andrews
J. M. Andrews
SCS. J. Connor
S. J. Connor
IGIBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group
IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group

3 April 2017 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
NMN. Mitrev
N. Mitrev
VKV. Kariyawasam
V. Kariyawasam
RLRupert Leong
Rupert Leong
Linked ContentThis article is linked to Yarur et al paper. To view this article visit https://doi.org/10.1111/apt.13970.

3 July 2023 in International Journal of Adolescent Medicine and Health
Verified
Journal Article
Closed access
NKNeda Karimi
Neda Karimi
ALAnnabelle Lukin
Annabelle Lukin
AMAlison R. Moore
Alison R. Moore
JPJoseph Louis Pipicella
Joseph Louis Pipicella
RKRia Kanazaki
Ria Kanazaki
SCSusan J. Connor
Susan J. Connor
Objectives: This study explored the variation in emerging adults’ communication with gastroenterologists around the management of inflammatory bowel disease (IBD). Methods: Nineteen emerging adults with IBD aged 18–25 and seven gastroenterologists participated in the study. Outpatient specialist consultations of consenting participants were audio-recorded and transcribed. Transcribed consultations were analysed in terms of the linguistic structure of the consultations and the gastroenterologist-patient role relationship. Results: Variations in the emerging adults’ communication with their gastroenterologists stem partly from variation in their ability, opportunity, or need to contribute to the different phases of the consultation and partly from variations in the gastroenterologists’ style of communication. Gastroenterologists differed in the construction of their role relationship with the patient, resulting in variations in employing empowering strategies including eliciting, exploring, and clarifying the patient’s concerns, sharing clinical reasoning, and validating the patient experience. Variations were also observed in the length of appointments and the gastroenterologists’ assessment and addressing of adherence issues. Techniques used by the gastroenterologist varied (1) from simply confirming adherence, to a comprehensive assessment of the patient’s understanding of their management plan and their feedback, and (2) from use of persuasion to values calibration. Conclusions: Evidence-based consumer interventions and communication guidelines for clinicians are needed to address the identified variations in providing care to emerging adults living with chronic conditions.

21 July 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
MAMichael Au
Michael Au
PLPatrick Low
Patrick Low
MRMichael Rennie
Michael Rennie
MMMarriam Mohseni
Marriam Mohseni
YSYang Song
Yang Song
VKViraj Kariyawasam
Viraj Kariyawasam
Introduction Colonoscopy plays important roles in bowel cancer screening and treatment. Poor bowel preparation occurs in 20–25% of colonoscopies. This negatively impacts adenoma and sessile serrated lesion detection rates, procedural time, requirement for repeat colonoscopies, healthcare costs and likelihood of patient withdrawal from screening programmes. It is unclear whether a combination of multimedia modalities can improve bowel preparation quality, adenoma detection rates and patient-reported measures in those undergoing colonoscopy assessment. Methods The DIGICLEAN trial is a prospective, parallel, multicentre, colonoscopist-blinded, randomised controlled trial. The trial will enrol 1294 participants aged 45 years and older who are indicated for a colonoscopy as an outpatient with a positive faecal occult blood test, iron deficiency anaemia or rectal bleeding. Participants will be randomised into the interventional arm, where bowel preparation instructions are delivered via a web-based application which uses scheduled short messaging service, regular patient survey assessment, email and videos; or the control arm, where routine standard written, verbal or emailed instructions are administered. The web-based application will assess patient-reported bloating, constipation and dietary adherence leading up to the colonoscopy. Depending on patient responses, additional aperients may be encouraged digitally in the interventional arm with same instructions made available in written format for the control arm. Patient-reported measures will be collected in both arms the day after the procedure using the validated Newcastle ENDOPREM questionnaire. In some sites, participants will undergo digital pre-anaesthetic screening as well. The co-primary endpoints are the adenoma detection rates and patient-reported measures taken after the colonoscopy. Ethics and dissemination Ethics approval for this study was obtained from the Western Sydney Local Health District Human Research Ethics Committee (2022/ETH00059). Findings will be reported at national and international gastroenterology meetings and published in peer-reviewed journals. Trial registration number ACTRN12622000747729.

14 January 2020 in British Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
NMNikola Mitrev
Nikola Mitrev
VKViraj Kariyawasam
Viraj Kariyawasam
Click on the article title to read more.

20 February 2026 in JCC Plus
Verified
Journal Article
Open access
BMBrook Maguire
Brook Maguire
NMNikola Mitrev
Nikola Mitrev
BBBrandon Baraty
Brandon Baraty
MAMichael Au
Michael Au
KSKyle Sorensen
Kyle Sorensen
VKViraj Kariyawasam
Viraj Kariyawasam
Background: Exclusive enteral nutrition (EEN) is potentially underutilised among adult inflammatory bowel disease (IBD) patients. We explore current practices and perceptions of EEN among patients, dietitians and gastroenterologists. Methods: Electronic surveys were developed for patients, dietitians and gastroenterologists in Australia. Surveys were distributed during national conferences and via social media platforms. Results: Surveys were taken by 67 patients, 135 dietitians and 100 gastroenterologists. Although 99% of the gastroenterologists were aware of EEN, only 39% routinely used EEN. Patient adherence was the most common reason for not utilising EEN, followed by limited dietitian support, limited clinician experience and cost. Of the surveyed patients, 64% had Crohn's Disease and 36% had ulcerative colitis. EEN had previously been tried by 21% patients of which 92% reported completing the entire EEN regimen. Majority (75%) were open to recommencing EEN in the event of future flares with/without additional medication. Among patients never treated with EEN, 72% preferred EEN with/without medication over medication alone. Most patients (95%) preferred remote dietitian consultations either exclusively (59%) or along with in‐person sessions (36%). Many dietitians (39%) did not feel they had adequate knowledge or experience to manage patients with IBD on EEN. Conclusion: Although majority of patients with IBD favour trying EEN, most gastroenterologists do not routinely use EEN. Gastroenterologists' perception of poor adherence as a major barrier may be incorrect. Majority of EEN experienced patients report completed the regimen and a willingness to re‐try it. A strong patient preference for remote consultations can improve access to experienced dietitians.